Literature DB >> 15665724

Inhibitors of NADPH oxidase reduce the organ injury in hemorrhagic shock.

Maha Abdelrahman1, Emanuela Mazzon, Michael Bauer, Inge Bauer, Sandrine Delbosc, Jean-Paul Cristol, Nimesh S A Patel, Salvatore Cuzzocrea, Christoph Thiemermann.   

Abstract

Reactive oxygen species contribute to the multiple organ dysfunction syndrome in hemorrhagic shock. Here, we investigate the effects of two chemically distinct inhibitors of NADPH oxidase on the circulatory failure and the organ dysfunction and injury associated with hemorrhagic shock in the anesthetized rat. Hemorrhage (sufficient to lower mean arterial blood pressure of 45 mmHg for 90 min) and subsequent resuscitation with shed blood resulted (within 4 h after resuscitation) in a delayed fall in blood pressure and in renal dysfunction and liver injury. Treatment of rats upon resuscitation with the NADPH oxidase inhibitors diphenylene iodonium (DPI, 1 mg/kg i.v.) reduced renal dysfunction and liver injury, whereas apocynin (3 mg/kg i.p.) did reduce the liver injury, but not the renal dysfunction caused by hemorrhagic shock. DPI and apocynin also attenuated the lung and intestinal injury (determined by histology) caused by hemorrhage and resuscitation. In the liver, DPI and apocynin abolished the increase in the formation of superoxide anions associated with hemorrhagic shock. However, neither DPI nor apocynin had a significant effect on the delayed circulatory failure caused by hemorrhage and resuscitation. In addition, DPI and apocynin did not reduce the increase in nitric oxide synthesis caused by hemorrhagic shock. Moreover, DPI reduced the activation of the transcription factor activator protein-1 caused by severe hemorrhage and resuscitation in the liver. Thus, we propose that an enhanced formation of superoxide anions by NADPH oxidase contributes to the liver injury caused by hemorrhagic shock, and that inhibitors of NADPH oxidase may represent a novel therapeutic approach for the therapy of hemorrhagic shock.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15665724     DOI: 10.1097/01.shk.0000151028.15377.f7

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  21 in total

1.  The role of NOX enzymes in ethanol-induced oxidative stress and apoptosis in mouse embryos.

Authors:  Jian Dong; Kathleen K Sulik; Shao-yu Chen
Journal:  Toxicol Lett       Date:  2009-12-21       Impact factor: 4.372

2.  Neutrophils counteract autophagy-mediated anti-inflammatory mechanisms in alveolar macrophage: role in posthemorrhagic shock acute lung inflammation.

Authors:  Zongmei Wen; Liyan Fan; Yuehua Li; Zui Zou; Melanie J Scott; Guozhi Xiao; Song Li; Timothy R Billiar; Mark A Wilson; Xueyin Shi; Jie Fan
Journal:  J Immunol       Date:  2014-09-29       Impact factor: 5.422

Review 3.  Antioxidant enzyme gene transfer for ischemic diseases.

Authors:  Jian Wu; James G Hecker; Nipavan Chiamvimonvat
Journal:  Adv Drug Deliv Rev       Date:  2009-02-20       Impact factor: 15.470

4.  A novel nontoxic inhibitor of the activation of NADPH oxidase reduces reactive oxygen species production in mouse lung.

Authors:  Intae Lee; Chandra Dodia; Shampa Chatterjee; John Zagorski; Clementina Mesaros; Ian A Blair; Sheldon I Feinstein; Mahendra Jain; Aron B Fisher
Journal:  J Pharmacol Exp Ther       Date:  2013-03-08       Impact factor: 4.030

5.  Lithocholic acid feeding results in direct hepato-toxicity independent of neutrophil function in mice.

Authors:  Benjamin L Woolbright; Feng Li; Yuchao Xie; Anwar Farhood; Peter Fickert; Michael Trauner; Hartmut Jaeschke
Journal:  Toxicol Lett       Date:  2014-04-15       Impact factor: 4.372

6.  Protective effects of apocynin and allopurinol on ischemia/reperfusion-induced liver injury in mice.

Authors:  Ping-Guo Liu; Song-Qing He; Yan-Hong Zhang; Jian Wu
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

7.  Rat strains bred for low and high aerobic running capacity do not differ in their survival time to hemorrhage.

Authors:  Harold G Klemcke; Kathy L Ryan; Steven L Britton; Lauren G Koch; Michael A Dubick; Victor A Convertino
Journal:  Exp Biol Med (Maywood)       Date:  2009-08-05

Review 8.  NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress.

Authors:  Becky A Diebold; Susan M E Smith; Yang Li; J David Lambeth
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

9.  Oral treatment with the NADPH oxidase antagonist apocynin mitigates clinical and pathological features of parkinsonism in the MPTP marmoset model.

Authors:  Ingrid H C H M Philippens; Jacqueline A Wubben; Bente Finsen; Bert A 't Hart
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-17       Impact factor: 4.147

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.